Technology ID
TAB-4618

The North American Lineage H7 (N.A H7) real-time (RT)-PCR Assay for Detection and Characterization of North American Lineage of A/H7 Avian Influenza Viruses

E-Numbers
E-022-2014-0
Lead Inventor
Lindstrom, Stephen
Lead IC
CDC
Co-Inventors
Wu, Kai-Hui
Berman, LaShondra
Warnes, Christine
Shu, Bo
ICs
CDC
Applications
Research Materials
Diagnostics
Therapeutic Areas
Infectious Disease
Development Stages
Analytical Assay Performance Stage
Research Products
Research Equipment

This technology includes an optimized N.A H7 influenza A virus subtyping real-time (RT)-PCR assay for detection and characterization of N.A A/H7 influenza viruses. Since 1995, infection of poultry with N.A A/H7 influenza viruses has greatly increased, the outbreaks of N.A A/H7 influenza viruses in poultry as well as wild birds occurred many times in Canada, Mexico and USA; meanwhile a number of human infection caused by N.A A/H7 influenza viruses have been confirmed following exposure to infected poultry. The assay may be licensed to commercial entities to manufacture and sell commercial reagents to research and clinical laboratories, and the assay will be in process to obtain clearance under FDA emergency use authorization for domestic human diagnostic testing procedures in the United States if necessary.

Commercial Applications
The assay may be licensed to commercial entities to manufacture and sell commercial reagents to research and clinical laboratories.

Competitive Advantages
The assay allows for the qualitative detection of N.A A/H7 influenza viruses in the shortest time with the highest sensitivity and specificity.
Licensing Contact:
Motley, Jonathan
jonathan.motley@nih.gov